- Home
- ROIV vs MTN Comparison
ROIV vs MTN Comparison
Compare ROIV & MTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- MTN
- Stock Information
- Founded
- ROIV 2014
- MTN 1997
- Country
- ROIV United Kingdom
- MTN United States
- Employees
- ROIV N/A
- MTN N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- MTN Services-Misc. Amusement & Recreation
- Sector
- ROIV Health Care
- MTN Consumer Discretionary
- Exchange
- ROIV Nasdaq
- MTN Nasdaq
- Market Cap
- ROIV 8.8B
- MTN 7.1B
- IPO Year
- ROIV N/A
- MTN 1997
- Fundamental
- Price
- ROIV $11.57
- MTN $184.48
- Analyst Decision
- ROIV Strong Buy
- MTN Hold
- Analyst Count
- ROIV 8
- MTN 10
- Target Price
- ROIV $17.93
- MTN $205.30
- AVG Volume (30 Days)
- ROIV 5.3M
- MTN 666.6K
- Earning Date
- ROIV 02-11-2025
- MTN 12-09-2024
- Dividend Yield
- ROIV N/A
- MTN 4.82%
- EPS Growth
- ROIV N/A
- MTN 5.26
- EPS
- ROIV 5.89
- MTN 6.16
- Revenue
- ROIV $129,128,999.00
- MTN $2,886,901,000.00
- Revenue This Year
- ROIV $15.98
- MTN $5.61
- Revenue Next Year
- ROIV N/A
- MTN $4.33
- P/E Ratio
- ROIV $2.06
- MTN $29.90
- Revenue Growth
- ROIV 145.68
- MTN 0.64
- 52 Week Low
- ROIV $9.69
- MTN $165.00
- 52 Week High
- ROIV $13.06
- MTN $236.92
- Technical
- Relative Strength Index (RSI)
- ROIV 41.56
- MTN 49.81
- Support Level
- ROIV $11.72
- MTN $187.99
- Resistance Level
- ROIV $12.22
- MTN $194.47
- Average True Range (ATR)
- ROIV 0.30
- MTN 6.51
- MACD
- ROIV -0.09
- MTN -1.21
- Stochastic Oscillator
- ROIV 15.24
- MTN 41.25
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About MTN Vail Resorts Inc.
Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.